Search Results - Fineman, Mark, PhD

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study

    Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study by Buse, John B, Prof, Nauck, Michael, Prof, Forst, Thomas, Prof, Sheu, Wayne H-H, Prof, Shenouda, Sylvia K, PhD, Heilmann, Cory R, PhD, Hoogwerf, Byron J, MD, Gao, Aijun, PhD, Boardman, Marilyn K, PharmD, Fineman, Mark, PhD, Porter, Lisa, MD, Schernthaner, Guntram, Prof

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: A randomized, placebo-controlled, single-blind, dose-escalation, crossover study

    Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: A randomized, placebo-controlled, sin... by Malloy, Jaret, PhD, Capparelli, Edmund, PharmD, Gottschalk, Michael, MD, PhD, Guan, Xuesong, PhD, Kothare, Prajakti, PhD, Fineman, Mark, MAS

    Published in Clinical therapeutics
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: